Common Stock (Details Narrative) - USD ($)				1 Months Ended	3 Months Ended
	Dec. 05, 2024	Aug. 08, 2024	Mar. 12, 2024	Mar. 24, 2025	Mar. 31, 2025	Dec. 31, 2024
Common Stock, Shares Outstanding					100,746,467	96,097,485
Common Stock, Shares Issued					100,746,467	96,097,485
Common Stock, Shares Par Value					$ 0.001	$ 0.001
Issued shares of restricted common stock					97,553
Common Stock, Shares Authorized					175,000,000	175,000,000
Equity Distribution Agreement [Member]
Common stock shares sold					448,706
Commissions and fee					$ 262,484
2022 EDA [Member]
Common stock shares sold					1,945,838
Commissions and fee					$ 2,400,000
Securities Purchase Agreement
Agreement of several purchases offering, Description	(i) 445,648 shares to the Insider Investors at an offering price of $0.5722 per share and (ii) a further 2,857,389 shares of our common stock (the “December 2024 Warrant Investor Shares” and, together with the Insider Shares, the “December 2024 Shares”), together with 2,857,389 common stock purchase warrants to purchase up to 2,857,389 shares of our common stock (the “Form A Warrants”) and 2,857,389 common stock purchase warrants to purchase up to 1,428,693 shares of our common stock (the “Form B Warrants” and, together with the Form A Warrants, the “December 2024 Warrants”), at a combined offering price of $0.5722 per December 2024 Warrant Investor Share and accompanying December 2024 Warrants, to certain existing stockholders of the Company and new investors (collectively, the “Warrant Investors”). The December 2024 Shares, Form A Warrants, and Form B Warrants were separately issued. Each Form A Warrant has an exercise price per share of $0.5722 and each Form B Warrant has an exercise price per share of $0.71525. Each December 2024 Warrant is exercisable on or after December 9, 2024 through and until December 9, 2029. The net proceeds received by the Company for the issuance and sale of the December 2024 Shares and the December 2024 Warrants was $1.9 million, before deducting offering expenses of $0.1 million paid by the Company			(i) 2,363,636 shares of the Company’s common stock to certain of its directors and executive officers, and certain of its existing stockholders (collectively, the “Insiders”) at an offering price of $0.55 per share (the “Insider Shares”), and (ii) 1,739,087 shares of common stock (the “March 2025 Warrant Investor Shares” and, together with the Insider Shares, the “March 2025 Shares”), together with common stock purchase warrants to purchase up to 1,739,087 shares of common stock (the “March 2025 Warrants”), at a combined offering price of $0.55 per March 2025 Warrant Investor Share and accompanying March 2025 Warrant, to certain other existing stockholders of the Company and new investors (collectively, the “Warrant Investors”). Each March 2025 Warrant has an exercise price per share of $0.66, and is exercisable on or after March 26, 2025 through and until March 26, 2030. The Insiders did not receive any March 2025 Warrants in the offering. The net proceeds received by the Company for the issuance and sale of the March 2025 Shares and the March 2025 Warrants was $2.3 million, before deducting offering expenses of $0.1 million paid by the Company
Common stock shares sold		9,170,000
Pre-Funded Warrants		3,557,273
Exercise price		$ 0.001
Offering price		$ 0.55
Offering expenses		$ 100,000
Issuance and sale of the Securities		$ 6,400,000
Warrants issued to purchase common shares		381,818
Securities Purchase Agreement | Series B Warrants [Member]
Pre-Funded Warrants		12,727,273
Exercise price		$ 0.57
Securities Purchase Agreement | Series A Warrants [Member]
Pre-Funded Warrants		12,727,273
Exercise price		$ 0.57
Offering price		$ 0.549
License Agreement
Issued shares of restricted common stock			129,132
Price per share			$ 0.97